Stocktoria

aTYR PHARMA INC ATYR

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2015-05-07 · LEI

aTYR PHARMA INC statistics & valuation

P / B0.8×
Net margin-39009.5%
FCF margin-32664.7%
Return on capital-99.7%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-3844.50% -155.20% -436.50% -14274.50% -27243.80% -39009.50% 2016201720182019202020212022202320242025
Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-5445.00% -152.20% -446.80% -15557.80% -28899.60% -40856.30% 2016201720182019202020212022202320242025
Return on equity (%)
-92.10% -75.00% -102.60% -76.60% -51.30% -30.90% -63.40% -55.60% -91.40% -109.80% 2016201720182019202020212022202320242025
Shares outstanding
23.7M 29.8M 2.2M 3.9M 11.0M 27.8M 29.5M 63.3M 84.0M 98.0M 2016201720182019202020212022202320242025
Net debt ($)
-$29.2M -$6.4M -$14.7M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-71.80% -53.90% -65.40% -44.80% -41.90% -29.20% -47.30% -41.80% -66.10% -79.70% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-4761.10% -148.30% -419.10% -10605.10% -29440.00% -32664.70% 2016201720182019202020212022202320242025
Debt / equity (×)
0.15× 0.23× 0.25× 2016201720182019202020212022202320242025
EPS ($)
-$1.77 -$1.77 -$1.60 -$0.94 -$0.86 -$0.80 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin-40856.3%-28899.6%-15557.8%-446.8%-152.2%-5445.0%
Net margin-39009.5%-27243.8%-14274.5%-436.5%-155.2%-3844.5%
FCF margin-32664.7%-29440.0%-10605.1%-419.1%-148.3%-4761.1%
Return on assets-79.7%-66.1%-41.8%-47.3%-29.2%-41.9%-44.8%-65.4%-53.9%-71.8%
Return on equity-109.8%-91.4%-55.6%-63.4%-30.9%-51.3%-76.6%-102.6%-75.0%-92.1%
Debt / equity0.25×0.23×0.15×
Current ratio5.305.486.275.8318.896.062.474.698.378.77

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.